We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of CERE yet.

CERE Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q4 2024, worth a combined $0 — down 100% from $20.7K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CERE and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $15.5K sold.

  • 0 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q4 2024, down from 2 in Q3 2024.
  • Funds reported $0 of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q4 2024 and 2 closed out, a net change of -2 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q4 2024 was IFP Advisors, an estimated $15.5K sold.

Based on aggregated 13F filings for Q4 2024.